Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 16, 2024 | «Оземпик» превратили в гидрогель.Его не надо колоть еженедельно, а достаточно нанести раз в месяц | Исследователи из Франции разработали систему введения семаглутида один раз в месяц на основе гидрогеля, что значительно упрощает лечение диабета и контроль веса. Она будет представлена на ежегодном собрании Европейской ассоциации по изучени... |
| May 28, 2024 | The High Cost of Diabetes Drugs: A Barrier to Health | In the realm of healthcare, the issue of affordability and access to essential medications is a critical concern that affects the well-being of individuals, particularly those suffering from chronic conditions like diabetes. The soaring pri... |
| May 25, 2024 | Health | High price of popular diabetes drugs deprives low-income people of effective treatment | Supply shortages and insurance hurdles for this powerful class of drugs, called GLP-1 agonists, have left many people who are suffering from diabetes and obesity without the medicines they need to stay healthy. One root of the problem is th... |
| As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge | Drugmakers are jockeying to capitalize on the next major innovation coming to the blockbuster weight loss industry. For now, one experimental oral drug from Eli Lilly appears to have an edge over pills from Novo Nordisk and Pfizer — even th... |
Reviews 0
FAQ about Type 2 Diabetes Medicine
What has the press written about Type 2 Diabetes Medicine?
Parsers VC has collected 5 articles mentioning Type 2 Diabetes Medicine, among them “«Оземпик» превратили в гидрогель.Его не надо колоть еженедельно, а достаточно нанести раз в месяц” (Sep 16, 2024) and “The High Cost of Diabetes Drugs: A Barrier to Health” (May 28, 2024).
Is Type 2 Diabetes Medicine still active?
Yes, Type 2 Diabetes Medicine is active; its latest activity on Parsers VC dates from Jan 27, 2026.